Phase-3 study to evaluate efficacy and safety of ertugliflozin monotherapy.
Read More »Yearly Archives: 2017
Lowering the Risk of Diabetes By Just Sitting Less
A new study suggests that people who spend time walking or even just standing instead of sitting may be at lower risk of type 2 diabetes.
Read More »Physical Activity Is Only One Part of the Equation
As an exercise physiologist, I first and foremost focus on the physical activity part for management of blood glucose levels, often stating that being active will increase insulin action, lower blood glucose levels, and make diabetes management easier. In reality, not all of those benefits are fully evident in many cases. In fact, they usually cannot be counted on unless you take into account myriad other factors that can have an equally—if not more—dramatic effect on blood glucose management.
Read More »Question #871
Hypoglycemia is a potential side effect of which of the following classes of drugs: 1) Insulins 2) Sulfonylureas 3) Meglitinides 4) Amylin mimetics 5) All of the above Follow the link to see the right answer!
Read More »Jan. 31, 2017
Over the past three weeks, we have been sharing a special feature from Dr. Altamash Shaikh on the unique situation of diabetes in India. We have looked at the reasons, challenges, and causes for the rapid increase in diabetes in the second most populated country in the world. This week, …
Read More »Life Happens to Our Patients Too. Be Understanding.
Woman, type 1 diabetes, 63 years of age. Well-educated diabetes wise. Reached out to me saying: "HELP!! Normally I take 10 units of Toujeo at 9 pm. I did that last night. This morning I meant to take an additional 2 units because I'm not getting any exercise due to a knee injury. By mistake I took my usual dose of 10 units." Before I read the rest of her email, I thought, I know her. She knows what to do. She wears a CGM, she’ll be watching that. Then I read on...
Read More »Altamash Shaikh Part 4, The Diabetes Solution
Dr. Altamash Shaikh talks with Diabetes in Control Associate Medical Editor Joy Pape at the 2016 AACE Meeting. In part 4, the conclusion of this Exclusive Interview, Dr. Shaikh gives his thoughts on solving the diabetes problem in the Indian community.
Read More »EMPA-REG Outcome Trial, Part 7
In this week's Homerun Slides, the ratios of the adverse events in patients and their tolerability of the placebo vs empagliflozin.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #60: Mechanisms of Insulin Signal Transduction Part 4 of 8
PI-3 kinase pathways: regulation of metabolism and gene expression: Signal transduction for insulin’s metabolic effects also diverges from insulin receptor substrate proteins and proceeds via the PI-3 kinase pathway. The first committed step involves type 1A PI-3 kinase, a heterodimer consisting of a p85 regulatory subunit and a p110 catalytic subunit. In quiescent cells, the regulatory subunit maintains a state of low activity for the catalytic subunit.
Read More »Jan. 28, 2017
For the past 15 years, we have been advocates of low carb and ultra low carb diets. We were the first publication to bring you the logic of low carb and have provided years of coverage of Dr. Richard Bernstein’s low carb methods for controlling glucose levels in type 1 …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.